Q4 2025 earnings call highlights: guidance, EPS outlook, market share gains, cost cuts, Dermacosmetics sale and 2026 risks—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results